Finceramica is a company which develops, manufactures and markets innovative therapeutic solutions for the biomedical sector. The work carried out at Finceramica lies at the junction between the thousand-year old evolution of ceramic processes and innovation in biomaterials, biosciences and "regenerative surgery". Our research activities revolve around the human being and the specific needs of patients and surgeons. Our technology platform is a concrete answer to the daily requirements faced by orthopaedic surgery, neurosurgery and maxillofacial surgery.

The innovative technologies developed by Finceramica in collaboration with internationally renowned research institutes have paved the way to new generations of biomaterials able to interact with and integrate in the human body, and eventually regenerate damaged bone tissues. One of the materials Finceramica is investigating most closely is hydroxyapatite, the bioceramic material which makes up 70% of the human bone. Once implanted, new generation hydroxyapatite-based biomaterials form an ideal micro-environment to biologically support the development of the new bone.

Our story

Finceramica was established in 1987 at the initiative of a researcher working for the then IRTEC-CNR (Institute for Science and Technology for Ceramics-National Research Council), who for long had been focusing on the biomedical field. All the stakeholders, who were private subjects, believed in his innovative ideas and decided to make them come to life. In 1992 the company started operating as a spin-off of the Institute for Science and Technology for Ceramics of the National Research Council, with the Tampieri brothers, Federico, Adriano and Giovanni, participating in its equity.